Tenaya Therapeutics Inc (NASDAQ: TNYA) is -62.24% lower on its value in year-to-date trading and has touched a low of $0.39 and a high of $6.47 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TNYA stock was last observed hovering at around $0.51 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $0.54, the stock is -38.04% and -51.71% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.05 million and changing 6.78% at the moment leaves the stock -76.95% off its SMA200. TNYA registered -91.43% loss for a year compared to 6-month loss of -76.62%.
The stock witnessed a -44.01% gain in the last 1 month and extending the period to 3 months gives it a -83.73%, and is 22.73% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 16.26% over the week and 15.08% over the month.
Tenaya Therapeutics Inc (TNYA) has around 97 employees, a market worth around $83.28M and $0.00M in sales. Distance from 52-week low is 37.02% and -91.65% from its 52-week high. The company has generated returns on investments over the last 12 months (-107.18%).
The EPS is expected to grow by 33.16% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Tenaya Therapeutics Inc (TNYA) Top Institutional Holders
The shares outstanding are 154.22M, and float is at 127.16M with Short Float at 10.51%.
The top institutional shareholder in the company is COLUMN GROUP LLC with over 9.4 million shares valued at $29.14 million. The investor’s holdings represent 10.968% of the TNYA Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 7.62 million shares valued at $23.63 million to account for 8.8935 of the shares outstanding. The other top investors are CASDIN CAPITAL, LLC which holds 6.73 million shares representing 7.8558% and valued at over $20.87 million, while BLACKROCK INC. holds 5.0308 of the shares totaling 4.07 million with a market value of $12.63 million.
Tenaya Therapeutics Inc (TNYA) Insider Activity
The most recent transaction is an insider sale by Higa Tomohiro, the company’s SVP, Finance. SEC filings show that Higa Tomohiro sold 2,482 shares of the company’s common stock on Mar 10 ’25 at a price of $0.54 per share for a total of $1336.0. Following the sale, the insider now owns 99690.0 shares.
Tenaya Therapeutics Inc disclosed in a document filed with the SEC on Mar 10 ’25 that Tingley Whittemore (Chief Medical Officer) sold a total of 7,398 shares of the company’s common stock. The trade occurred on Mar 10 ’25 and was made at $0.54 per share for $3983.0. Following the transaction, the insider now directly holds 0.17 million shares of the TNYA stock.
Still, SEC filings show that on Mar 10 ’25, Ali Faraz (Chief Executive Officer) disposed off 9,741 shares at an average price of $0.54 for $5245.0. The insider now directly holds 320,514 shares of Tenaya Therapeutics Inc (TNYA).
